HealthCare Royalty

HealthCare Royalty ("HCRx") is a leading royalty acquisition company focused on commercial or near-commercial stage biopharmaceutical products. HCRx has invested $5+ billion in more than 85 biopharma products since inception and has offices in Stamford (CT), San Francisco, Boston and London. The HCRx team consists of 33 individuals (including our Senior Advisors), including former pharmaceutical executives, scientists, physicians, bankers, research analysts and consultants. Our philosophy is simple - We are asset-focused investors seeking to identify compelling investment opportunities that will generate long-term value. We target healthcare assets with significant clinical value and strong barriers to entry that are meaningful to their marketer. We also look for assets that will produce sustainable revenues over an extended period of time. Our investments span the pharmaceutical, biotechnology and specialty pharmaceuticals sectors. Our investment platform is designed to serve as a long-term capital resource for our partners; flexible and directly aligned with their business models and objectives. Our team utilizes multiple investment approaches to help our partners achieve their goals including: customized debt, royalty monetization, and revenue participation financings. Since 2003, HCRx's senior professionals have completed more than 60 healthcare investments. HEALTHCARE ROYALTY? IS A REGISTERED TRADEMARK OF HEALTHCARE ROYALTY MANAGEMENT, LLC.

网站

https://www.hcrx.com

HealthCare Royalty的外部链接

所属行业

投资管理

规模

11-50 人

总部

Stamford，Connecticut

类型

私人持股

创立

2007

领域

Private Equity、Growth Capital、Healthcare Royalty Financing、Pharmaceuticals、Biotechnology、Specialty Pharmaceuticals、Medical Devices/Diagnostics和Non-Dilutive Financing